Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High risk of lung cancer in surfactant-related gene variant carriers.

The European respiratory journal·2024
Same author

Score to Predict the Occurrence of Pneumothorax After Computed Tomography-guided Percutaneous Transthoracic Lung Biopsy.

Journal of thoracic imaging·2023
Same author

<i>Bifidobacterium</i> Species Colonization in Infancy: A Global Cross-Sectional Comparison by Population History of Breastfeeding.

Nutrients·2022
Same author

Management of patients with pulmonary mycobacteriosis in France: a multicenter retrospective cohort study.

BMC pulmonary medicine·2021
Same author

Inflammatory and immunological profile in COPD secondary to organic dust exposure.

Clinical immunology (Orlando, Fla.)·2021
Same author

Exposure Assessment Tools for Hypersensitivity Pneumonitis. An Official American Thoracic Society Workshop Report.

Annals of the American Thoracic Society·2020
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Related Experiment Video

Updated: Jul 6, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

[Occupational interstitial lung diseases].

Paul De Vuyst1, Jean-Charles Dalphin

  • 1Service de pneumologie, hôpital Erasme, 1070 Bruxelles, Belgique. pdevuyst@ulb.ac.be

La Revue Du Praticien
|March 7, 2008
PubMed
Summary
This summary is machine-generated.

Pneumoconioses, lung diseases from mineral dust, remain a concern due to historical and novel exposures. Early diagnosis using high-resolution CT (HRCT) and other tests is crucial for managing these occupational lung diseases.

Related Experiment Videos

Last Updated: Jul 6, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Area of Science:

  • Pulmonary Medicine
  • Occupational Health
  • Radiology

Background:

  • Pneumoconioses result from inhaling mineral or metallic dust, with ongoing risks from new industrial materials and exposures.
  • Diseases diagnosed today may stem from exposures decades prior, highlighting the long latency of these conditions.
  • Susceptible individuals can develop severe conditions like beryllium-related lung disease even with low-level exposure.

Purpose of the Study:

  • To emphasize the persistent threat of pneumoconioses and hypersensitivity pneumonitis.
  • To highlight the diagnostic challenges and the importance of advanced imaging and testing.
  • To underscore the necessity of early detection and intervention for occupational lung diseases.

Main Methods:

  • Review of diagnostic contributions of high-resolution computed tomography (HRCT) scans.
  • Discussion of pathological, mineralogical, and immunological techniques for differential diagnosis.
  • Emphasis on clinical assessment, serological tests, bronchoalveolar lavage, and HRCT for hypersensitivity pneumonitis.

Main Results:

  • HRCT scans offer sensitive and specific diagnostic contributions for pneumoconioses.
  • Clinical approach, alongside serological tests and bronchoalveolar lavage, is essential for diagnosing hypersensitivity pneumonitis.
  • Early exposure cessation is key to preventing chronic respiratory failure.

Conclusions:

  • Accurate diagnosis of occupational lung diseases like pneumoconioses and hypersensitivity pneumonitis is critical due to potential misdiagnosis consequences.
  • Integrated diagnostic approaches combining imaging, laboratory tests, and clinical evaluation are vital.
  • Timely intervention, including exposure removal and corticosteroid treatment for severe hypersensitivity pneumonitis, improves outcomes.